Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer
Clinical trial NCT06815497 · RECRUITING
Trial details
- NCT number
- NCT06815497
- Sponsor
- Tyler J Curiel
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-21
- Primary completion
- 2027-04-14
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.